
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Accelerated Enrollment Solutions, a business unit of Pharmaceutical Product Development, LLC, has acquired the clinical research site business of Bioclinica. This acquisition now expands AES’ global footprint in patient access and site conduct across five continents, 20 countries, over 180 research sites and more than 100 million households.
For more information, click






